SCHEMBL10288078

SCHEMBL10288078

COC(=O)c1c(N2CCOCC2)sc(N2CCOCC2)c1C(=O)OC

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.51
▸ POLB P06746 3/20 0.51
▸ CNR2 P34972 1/20 0.46
▸ HSD17B10 Q99714 3/20 0.44
▸ ALOX15 P16050 3/20 0.44
▸ HPGD P15428 2/20 0.44
▸ MGLL Q99685 1/20 0.44
▸ MAPT P10636 3/20 0.43
▸ KDM4E B2RXH2 2/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ RXFP1 Q9HBX9 1/20 0.43
▸ TSHR P16473 1/20 0.43
▸ MAPK1 P28482 1/20 0.42
▸ RECQL P46063 1/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.42
▸ MRGPRX4 Q96LA9 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10298244 0.89 ALDH1A1 (0.44) ALDH1A1POLBCNR2HSD17B10ALOX15
SCHEMBL10288080 0.82 HSD17B10 (0.53) ALDH1A1HSD17B10ALOX15HPGDMAPT
SCHEMBL10288334 0.80 ALDH1A1 (0.50) ALDH1A1POLBHSD17B10HPGDMAPT
SCHEMBL10288077 0.79 ALDH1A1 (0.44) ALDH1A1POLBCNR2HSD17B10ALOX15
SCHEMBL18396188 0.77 ALDH1A1 (0.51) ALDH1A1POLBHSD17B10ALOX15HPGD
SCHEMBL18394896 0.77 ALDH1A1 (0.48) ALDH1A1POLBHSD17B10ALOX15HPGD
SCHEMBL3757634 0.76 PIK3CD (0.47) ALDH1A1POLBCNR2HSD17B10MAPT
SCHEMBL3120329 0.76 ALDH1A1 (0.47) ALDH1A1POLBCNR2HSD17B10ALOX15
SCHEMBL20098347 0.76 ALDH1A1 (0.45) ALDH1A1HSD17B10ALOX15HPGDMGLL
SCHEMBL623010 0.75 PIK3CA (0.50) ALDH1A1POLBHPGDKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150175563-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARM INC (US) 2015-06-25 — — US disclosed
US-20150175593-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARM INC (US) 2015-06-25 — — US disclosed
US-8796271-B2 Heteroaryls and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2014-08-05 — — US disclosed
US-8796268-B2 Heteroaryls and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2014-08-05 — — US disclosed
US-20120178723-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-07-12 — — US disclosed
US-20120172345-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-07-05 — — US disclosed
WO-2012021696-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-02-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120172345-A1 HETEROARYLS AND USES THEREOF PIK3R1, PIK3R2, PIK3R3 ALDH1A1 429/4885POLB 1367/4885CNR2 778/4885
US-20150175563-A1 HETEROARYLS AND USES THEREOF PIK3R1, PIK3R2, PIK3R3 ALDH1A1 429/4885POLB 1367/4885CNR2 778/4885
US-20120178723-A1 HETEROARYLS AND USES THEREOF PIK3R1, PIK3R2, PIK3R3 ALDH1A1 395/4885POLB 1823/4885CNR2 583/4885
US-20150175593-A1 HETEROARYLS AND USES THEREOF PIK3R1, PIK3R2, PIK3R3 ALDH1A1 395/4885POLB 1823/4885CNR2 583/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback